BioSpace News Archive

Thermo Scientific Neoma Multicollector ICP-MS extracts reliable isotopic data from even the smallest samples, with new levels of sensitivity, accuracy and productivity

PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, today announced the expansion of its team of scientific advisors, which is now comprised of leaders in the fields of nutrition, pediatrics and sports medicine

Merz Therapeutics today announced Health Canada’s notice of compliance for XEOMIN® (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, associated with neurological disorders in adult patients

GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer.

Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company’s Genius AI™ Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.

Immunomic Therapeutics, Inc. (ITI) announced today that it will be presenting at the 2nd Annual Glioblastoma Drug Development Virtual Summit. On Wednesday, December 9th, Chief Executive Officer at ITI, Dr. Bill Hearl, will be presenting a talk titled, “Adaptive T-cell Immunotherapy for Newly Diagnosed Glioblastoma: Using Targeted Antigen Presentation to Enhance Immune Responses.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), and Russian Direct Investment Fund (RDIF) announced today that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India.

Applied UV Announces U.S. Patent to be Issued for a System to Neutralize Pathogens on Tactile Surfaces, Including Bank ATMs

Bearpac Medical, LLC is pleased to announce that the FDA has granted 510(k) clearance for the Passio Pump Drainage System for the additional indication of home use to provide therapy for malignant and other recurrent pleural effusions.

Partnership Between Best-in-Class ACP Organizations Supports Person-Centered Care by Enabling Doctors and Nurses to Quickly Understand Patient Care Wishes